Skip to content
2000
image of Therapeutic Adherence in Moroccan Hypertensive Patients: Influence of Socioeconomic Status and Fixed-Dose Combination Therapy

Abstract

Introduction

Hypertension represents a major public health challenge, contributing to the global health burden. Lifestyle modifications and pharmacotherapeutic interventions are the cornerstones in the management of hypertension. However, suboptimal adherence remains a critical impediment to achieving desired clinical outcomes, stemming from a complex interplay of socioeconomic factors, access to care, and affordability of medications. Therefore, the objective of this study was to assess adherence to lifestyle modifications and drug therapy and their associated factors.

Methods

A monocentric cross-sectional study was conducted on 200 hypertensive patients from July 1st to October 30, 2022. Participants were selected using a consecutive sampling technique. Adherence to lifestyle modifications was assessed through questions filled in a data sheet, with consumption of salt and the DASH diet evaluated using a Food Frequency Questionnaire and the Hill-Bone Compliance to High Blood Pressure Therapy Scale, while medication adherence was assessed using the Morisky Medication Adherence Scale with 4 items (MMAS-4).

Results

The overall adherence to lifestyle modifications was 39.8%, with good adherence to fruit and vegetable consumption at 59.5%, adherence to a low-salt diet at 43%, and physical activity at 24.5%. According to the MMAS-4, poor medication adherence was observed in 58.3% of our patients and was associated with advanced age (>60 years; p = 0.014), low socio-economic level (p = 0.012), and use of free-dose combination therapy ( = 0.001).

Discussion

Our study demonstrates that poor adherence critically undermines hypertension control, while patient education and fixed-dose combination therapies improve outcomes. However, variability across populations and healthcare contexts limits generalizability and warrants further multicenter research.

Conclusion

The findings of this study indicate that therapeutic adherence among individuals with hypertension remains suboptimal, highlighting the need for a comprehensive, multifactorial strategy to address the diverse and intersecting determinants of nonadherence.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/chyr/10.2174/0115734021398378251014103137
2025-11-03
2026-02-03

  • From This Site

    /content/journals/chyr/10.2174/0115734021398378251014103137
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Williams B. Mancia G. Spiering W. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur. Heart J. 2018 39 33 3021 3104 10.1093/eurheartj/ehy339 30165516
    [Google Scholar]
  2. Blacher J Czernichow S Iaria P Traitement non pharmacologique de l’hypertension artérielle. EMC - Cardiologie-Angéiol-ogie 2005 2 2 136 51 10.1016/j.emcaa.2005.03.002
    [Google Scholar]
  3. Andualem A. Gelaye H. Damtie Y. Adherence to lifestyle modifications and associated factors among adult hypertensive patients attending chronic follow-up units of dessie referral hospital, North East Ethiopia, 2020. Integr. Blood Press. Control 2020 13 145 156 10.2147/IBPC.S275575 33122940
    [Google Scholar]
  4. Mrabet H.E. Mlouki I. Nouira S. Hmaied O. Ben Abdelaziz A. El Mhamdi S. Cardiovascular risk factors in the Maghreb. A systematic review. Tunis. Med. 2021 99 1 120 128 33899179
    [Google Scholar]
  5. Guerra C. Conte E. Del Rio A.I. Motta J. Moreno Velásquez I. Quintana H.K. Medication adherence in hypertensive individuals in Panama 2019: a national cross-sectional study. Healthcare 2022 10 11 2244 10.3390/healthcare10112244 36360586
    [Google Scholar]
  6. Blacher J. Halimi J.M. Hanon O. Prise en charge de l’hypertension artérielle de l’adulte. Recommandations 2013 de la Société française d’hypertension artérielle. Presse Med. 2013 42 5 819 825 10.1016/j.lpm.2013.01.022 23528337
    [Google Scholar]
  7. Macquart de Terline D. Kramoh K.E. Bara Diop I. Poor adherence to medication and salt restriction as a barrier to reaching blood pressure control in patients with hypertension: Cross-sectional study from 12 sub-Saharan countries. Arch. Cardiovasc. Dis. 2020 113 6-7 433 442 10.1016/j.acvd.2019.11.009 32434710
    [Google Scholar]
  8. Lestari P. Suastika L. Widyadharma I. Relationship between medication adherence and hypertension status in public health center. Int J Med Rev Case Rep 2019 1
    [Google Scholar]
  9. Hassanein M. Adherence to antihypertensive fixed-dose combination among Egyptian patients presenting with essential hypertension. Egypt. Heart J. 2020 72 1 10 10.1186/s43044‑020‑00044‑6 32140895
    [Google Scholar]
  10. Smith W.C. Lee A.J. Crombie I.K. Tunstall-Pedoe H. Control of blood pressure in Scotland: The rule of halves. BMJ 1990 300 6730 981 983 10.1136/bmj.300.6730.981 2344507
    [Google Scholar]
  11. Gupta A.K. Arshad S. Poulter N.R. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: A meta-analysis. Hypertension 2010 55 2 399 407 10.1161/HYPERTENSIONAHA.109.139816 20026768
    [Google Scholar]
  12. Hedna Khedidja Adherence to antihypertensive therapy and elevated blood pressure: should we consider the use of multiple medications? PLoS One 2015 10 9 e0137451 10.1371/journal.pone.0137451
    [Google Scholar]
  13. Adidja N.M. Agbor V.N. Aminde J.A. Ngwasiri C.A. Ngu K.B. Aminde L.N. Non-adherence to antihypertensive pharmacotherapy in Buea, Cameroon: A cross-sectional community-based study. BMC Cardiovasc. Disord. 2018 18 1 150 10.1186/s12872‑018‑0888‑z 30041606
    [Google Scholar]
  14. Diriba D. Guta D. Adherence to lifestyle modifications and its associated factors among adult hypertensive patients attending their follow-up at public hospitals in West Shoa, Oromia, Ethiopia, 2023. J. Hum. Hypertens. 2025 39 3 192 198 10.1038/s41371‑025‑00991‑0 39962235
    [Google Scholar]
  15. Kishore S.P. Salam A. Rodgers A. Jaffe M.G. Frieden T. Fixed-dose combinations for hypertension. Lancet 2018 392 10150 819 820 10.1016/S0140‑6736(18)31814‑2 30215377
    [Google Scholar]
  16. Fixed-dose combination pharmacologic therapy to improve hypertension control worldwide: Clinical perspective and policy implications. J. Clin. Hypertens. 2018 21 1 4 15 10.1111/jch.13426
    [Google Scholar]
  17. Dhakal A K C T, Neupane M. Adherence to lifestyle modifications and its associated factors in hypertensive patients. J. Clin. Nurs. 2022 31 15-16 2181 2188 10.1111/jocn.16033 34498336
    [Google Scholar]
/content/journals/chyr/10.2174/0115734021398378251014103137
Loading
Therapeutic Adherence in Moroccan Hypertensive Patients: Influence of Socioeconomic Status and Fixed-Dose Combination Therapy
Bentham Science Publishers ; https://doi.org/10.2174/0115734021398378251014103137
/content/journals/chyr/10.2174/0115734021398378251014103137
/content/journals/chyr/10.2174/0115734021398378251014103137
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: cardiovascular disease ; therapeutic adherence ; high blood pressure ; Hypertension ; morisky medication adherence scale 4 ; fixed dose combination therapy

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test